Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Transplant Rev (Orlando). 2009 Oct;23(4):235–247. doi: 10.1016/j.trre.2009.07.001

Figure 8.

Figure 8

Survival curve comparing patients that exhibit de novo anti-HLA Class II antibodies vs. patients without anti-HLA Class II antibodies. Patients who produce Class II antibodies have significantly worse survival (p=0.006). (From Tambur AR, Pamboukian SV, Constanzo MR, et al. Transplantation 2005;80:1019–1025, with permission).